GlassScriptPhysician profile
Laurel A Obarto
NPI 1982398145
$630.70
in general payments reported to CMS, 2019-2025
11 companies · $484 in 2025
The $484 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $147 · 2025: $484.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $630.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $125.00 | 2025 | Camzyos |
| Medtronic, INC. | $110.94 | 2025 | Corevalve Evolut R |
| Gilead Sciences, INC. | $91.91 | 2024 | Epclusa |
| Abbvie INC. | $54.77 | 2024 | |
| Pfizer INC. | $51.51 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $47.43 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.51 | 2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $34.95 | 2025 | |
| Novo Nordisk INC | $32.72 | 2025 | Wegovy |
| Kestra Medical Technology Services, INC. | $31.29 | 2025 | Assure Wcd |
| Boston Scientific Corporation | $14.67 | 2025 | Watchman Access System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laurel Obarto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.